Answers are grounded in this paper and cite their sources.
The data suggest that monotherapy with colistin methanesulfonate, the parenteral form of colistin, and long dosage intervals may be problematic for the treatment of infections caused by multidrug-resistant K. pneumoniae, particularly for colistin-heteroresistant strains. Further investigation on combination therapy of colistin with other antibiotics is warranted.
No takes yet. Share an insight, caveat, or question.
Poudyal et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: